Article Details

Syros Pharmaceuticals' (SYRS) “Buy” Rating Reiterated at Cowen

Retrieved on: 2018-07-17 04:15:23

Tags for this article:

Click the tags to see associated articles and topics

Syros Pharmaceuticals' (SYRS) “Buy” Rating Reiterated at Cowen. View article details on hiswai:

Excerpt

<div><b>Two Sigma Investments</b> LP grew its stake in Syros Pharmaceuticals by 80.3% in the fourth quarter. <b>Two Sigma Investments</b> LP now owns 21,197 ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up